Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

LETROZOLE\RIBOCICLIB: Who Reports Side Effects? Age, Gender & Country Data

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

Gender Distribution

98.2%
Female
1.8%
Male

Age Information

The average age of patients reporting adverse events with LETROZOLE\RIBOCICLIB is 64.2 years.

Geographic Distribution

The majority of adverse event reports for LETROZOLE\RIBOCICLIB originate from US.

Report Summary & Outcomes

621
Total Reports
621
As Primary/Secondary Suspect
78
Deaths Reported
80
Hospitalizations
7
Life-Threatening
3
Disabilities

Reporting Timeline

First adverse event report: 20140806. Most recent report: 20250207. View full timeline →

More About LETROZOLE\RIBOCICLIB

LETROZOLE\RIBOCICLIB Full Profile Reports by Year Drug Interactions